roche holding ag transplant drug gets pregnancy warnings the food and drug administration said that cellcept a roche holding ag drug used for certain organ transplant patients was "associated with increased risk" of miscarriages and birth defects the fda and roche said women of childbearing age should have a negative pregnancy test within one week before starting cellcept cellcept is given to people who have received kidney heart or liver transplants to help keep the new organs healthy the drug is typically taken with other drugs designed to prevent the body from rejecting a transplanted organ roche sent a letter to doctors describing the pregnancy warnings which were added to an existing black box warning 
